PRINCIPAL FINANCIAL GROUP INC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$600,000
-43.9%
29,760
+4.0%
0.00%
-100.0%
Q2 2021$1,069,000
+36.5%
28,628
-6.5%
0.00%0.0%
Q1 2021$783,000
+10.6%
30,611
-4.8%
0.00%0.0%
Q4 2020$708,000
+175.5%
32,144
+124.6%
0.00%
Q3 2020$257,000
-60.6%
14,311
-44.4%
0.00%
-100.0%
Q2 2020$653,000
+240.1%
25,727
+146.7%
0.00%
Q1 2020$192,000
-12.7%
10,430
+4.5%
0.00%
Q4 2019$220,0009,9790.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders